TABLE 3.
Gender grouping analysis of premature acute myocardial infarction (AMI) patients.
| Men (n = 2,005) | Women (n = 508) | P-value | |
| Age, years | 48 (43, 51) | 59 (51.5, 62) | < 0.001 |
| Current smoker, n (%) | 1631 (81.3) | 20 (3.9) | < 0.001 |
| Hypertension, n (%) | 568 (28.3) | 243 (47.8) | < 0.001 |
| Diabetes, n (%) | 261 (13.0) | 146 (28.7) | < 0.001 |
| Dyslipidemia, n (%) | 1574 (78.5) | 323 (63.6) | < 0.001 |
| Overweight/Obesity, n (%) | 1435 (71.6) | 193 (38.0) | < 0.001 |
| Family history of CHD, n (%) | 153 (7.6) | 24 (4.7) | 0.022 |
| ST-segment elevation, n (%) | 1343 (67.0) | 310 (61.0) | 0.011 |
| Left main lesion, n (%) | 62 (3.3) | 22 (4.8) | 0.107 |
| LVEF < 50%, n (%) | 527 (31.3) | 140 (31.9) | 0.822 |
| Killip class II–IV, n (%) | 532 (26.5) | 227 (44.7) | < 0.001 |
| NT-proBNP peak, ng/ml | 796.0 (346.0, 1755.0) | 1567.5 (654.0, 4055.0) | < 0.001 |
| Out-of-hospital outcomes | |||
| All-cause death | 86 (4.3) | 52 (10.9) | < 0.001 |
| In-hospital outcomes | |||
| All-cause death | 31 (1.5) | 17 (3.3) | 0.008 |
| cardiovascular death | 30 (1.5) | 13 (2.6) | 0.099 |
| MACCEs | 242 (12.1) | 76 (15.0) | 0.080 |
| Cardiogenic shock | 89 (4.4) | 35 (6.9) | 0.023 |
CHD, Coronary heart disease; LVEF, Left ventricular ejection fraction; NT-proBNP, N terminal pro B type natriuretic peptide; MACCEs, Major adverse cardiovascular and cerebrovascular events.